Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42M Sell
1,833
-589
-24% -$807K 1.57% 20
2025
Q4
$2.59M Sell
2,422
-150
-6% -$156K 1.71% 23
2025
Q3
$2.49M Buy
2,572
+629
+32% +$494K 1.74% 21
2025
Q2
$1.56M Buy
1,943
+188
+11% +$135K 1.24% 42
2025
Q1
$1.16M Buy
1,755
+1,047
+148% +$762K 1.08% 43
2024
Q4
$491K Buy
+708
New +$508K 0.43% 59

Other funds holding ASML

Elevate Capital Advisors's ASML Position: Q1 2026 in Review

Elevate Capital Advisors reduced its ASML (ASML) stake by 24% in Q1 2026, selling an estimated $807K and leaving 1,833 shares worth $2.42M. The position accounts for 1.57% of the portfolio, ranked #20.

Elevate Capital Advisors first reported a position in ASML in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.59M in Q4 2025. 2,190 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

  • Elevate Capital Advisors held 1,833 shares of ASML worth $2.42M as of Q1 2026.
  • Elevate Capital Advisors sold 589 ASML shares in Q1 2026, an estimated $807K.
  • ASML made up 1.57% of Elevate Capital Advisors's portfolio in Q1 2026, its #20 holding.
  • Elevate Capital Advisors first reported a position in ASML in Q4 2024 and has held it in 6 quarters since.
  • Elevate Capital Advisors's ASML position peaked at $2.59M in Q4 2025.
  • 2,190 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Elevate Capital Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.